Evidence map›Paper›PMID 36266375›Full record

ArticlePharmaceutical research2022

Correction: Preparation and Evaluation of Low-Dose Calcitriol Dry Powder Inhalation as Host-Directed Adjunct Therapy for Tuberculosis.

D V Siva Reddy, Hasham Shaf, Reena Bharti, Trisha Roy, Sonia Verma, Sunil Kumar Raman, Khushboo Verma, Lubna Azmi, Lipika Ray, Jyotsna Singh and 3 more

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

D V Siva ReddyCSIR-Central Drug Research Institute, Lucknow, 226031, India.
Hasham ShafCSIR-Central Drug Research Institute, Lucknow, 226031, India.
Reena BhartiCSIR-Central Drug Research Institute, Lucknow, 226031, India.
Trisha RoyCSIR-Central Drug Research Institute, Lucknow, 226031, India.
Sonia VermaCSIR-Central Drug Research Institute, Lucknow, 226031, India.
Sunil Kumar RamanCSIR-Central Drug Research Institute, Lucknow, 226031, India.
Khushboo VermaCSIR-Central Drug Research Institute, Lucknow, 226031, India.
Lubna AzmiCSIR-Central Drug Research Institute, Lucknow, 226031, India.
Lipika RayCSIR-Central Drug Research Institute, Lucknow, 226031, India.
Jyotsna SinghCSIR-Indian Institute of Toxicology Research, Lucknow, 226001, India.
Amit Kumar SinghNational JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, 282004, India.
Madhav N MugaleCSIR-Central Drug Research Institute, Lucknow, 226031, India.
Amit MisraCSIR-Central Drug Research Institute, Lucknow, 226031, India. amit_misra@cdri.res.in.
Central Drug Research Institute · INAcademy of Scientific and Innovative Research · INIndian Institute of Toxicology Research · INNational JALMA Institute for Leprosy & Other Mycobacterial Diseases · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36266375
PMCPMC9828844
OpenAlexW4306922971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.